Categories: News

Vuzix Partners with VSee Lab Inc. to Deliver a Telehealth and Telemedicine Smart Glasses Solution

ROCHESTER, N.Y., April 9, 2019 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce a strategic partnership with VSee Lab Inc. (“VSee”), a San Jose-based video telehealth company, to introduce a telehealth and telemedicine smart glasses solution for Vuzix’ M300XL and Vuzix Blade Smart Glasses.

VSee provides a HIPAA-compliant video telehealth and telemedicine video conferencing solution that is used by more than 1,000 telemedicine companies operating all over the globe, including MDLIVE, Walgreens, McKesson, International SOS and DaVita, as well as numerous A-list healthcare systems such as Ascension, HealthPartners, Sutter, Trinity and Sentara. VSee was also selected by NASA to be the exclusive video conference solution on the International Space Station (ISS) because of its usability and its ability to adapt to poor network conditions.  It has been used by astronauts on board the ISS since 2014.

“The VSee telemedicine video conferencing platform is easy and simple to use.  We are excited to offer a telemedicine video conferencing smart glasses hardware option to our existing customers, first responders and to VSee’s extensive telemedicine customer base,” said Paul Travers, President and Chief Executive Officer at Vuzix. 

“While VSee previously worked with some early generation smart glasses solutions, the technology was not ready for telemedicine. We feel very privileged now to be partnering with Vuzix with its mature smart glasses offerings. Telemedicine video conferencing through smart glasses from Vuzix is a natural progression from tablets and computers for our customers.  We are excited to begin realizing telehealth smart glasses applications from remote training on imaging technology (CTs, ultrasounds) and inserting IVs to telesurgery to AR-enhanced video visits.  We look forward to continued collaboration between our two companies,” said Milton Chen, Chief Executive Officer at VSee.

VSee will be showcasing the smart glasses telehealth and telemedicine solution on the Vuzix M300XL and Vuzix Blade at the American Telemedicine Association (ATA) 2019 annual conference and expo in New Orleans April 14-16th in VSee booth #727.  More information can be found at http://www.ata2019.org/

The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during the second quarter of 2019.

About Vuzix Corporation

Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 153 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2019 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, Barcelona, Spain and Tokyo, Japan.  For more information, visit Vuzix website Twitter and Facebook pages.

About VSee
VSee is the video telehealth company behind NASA Space Station, Trinity, Ascension, DaVita, MDLIVE and 1,200+ customers, and the parent of This American Doc medical group—an airbnb-like marketplace for physician staffing. VSee empowers health organizations and practitioners to achieve better patient care and improved efficiency through simple, scalable telehealth. Its modular platform provides powerful flexibility for fast customization to a wide range of workflows from ER diversion to e-ICU to on-call specialist consults to chronic care management. Learn more at vsee.com.

Marketing Contact: Anne Chang, Marketing Director, VSee Lab anne@vsee.com Tel: (626) 513-1824

Forward-Looking Statements Disclaimer
Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to our business relationship and future opportunities with VSee, and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations, Vuzix Corporation ed_mcgregor@vuzix.com Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/vuzix-partners-with-vsee-lab-inc-to-deliver-a-telehealth-and-telemedicine-smart-glasses-solution-300828029.html

SOURCE Vuzix Corporation

Staff

Recent Posts

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

1 hour ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

1 hour ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

1 hour ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

1 hour ago

Nearly 50% of Young People Resolve to Quit Nicotine in 2025

EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024…

1 hour ago